Human papillomavirus (HPV) vaccines

Adele Visser
2011 CME MAY   unpublished
Human papillomavirus (HPV) infection has been estimated to cause 270 000 deaths worldwide annually from cervical cancer and approximately 80% of these occur in resource-poor countries. 1 In South Africa, cervical cancer is the second most common malignancy among women, with the highest rate among black women aged 66-69 years. 2 With the development of prophylactic HPV vaccines there are prospects of significant reduction in morbidity and mortality due to HPV infection and its complications. 3